Literature DB >> 27638741

[Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].

M Schützwohl1, E Voss2, M Stiawa3, H-J Salize2, B Puschner3, A Koch4.   

Abstract

BACKGROUND: During the past years the provision of mental healthcare for adults with intellectual disabilities (ID) has repeatedly been criticized; however, the number of relevant studies is still relatively few.
OBJECTIVE: The aim of the present study was to identify determinants for utilization of mental healthcare services and prescription of psychotropic medication in adults with mild to moderate ID.
MATERIAL AND METHODS: Analyses were based on data from 417 adults with mild to moderate ID, which had been collected within the cross-sectional MEMENTA study in three different regions of Germany. Logistic regression analyses were conducted to identify clinical and sociodemographic variables as predictors of utilization of mental healthcare services (n = 282) and psychotropic medication (n = 351).
RESULTS: Utilization of healthcare services and psychotropic medication were both associated with mental disorders and problem behavior. In addition, the likelihood of being treated with psychotropic medication and antipsychotic drugs was higher in adults living in residential homes.
CONCLUSION: The findings indicate a lack of adherence to existing guidelines in the treatment of adults with ID living in residential homes.

Entities:  

Keywords:  Health care utilization; Problem behavior; Psychotropic drugs

Mesh:

Substances:

Year:  2017        PMID: 27638741     DOI: 10.1007/s00115-016-0211-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities.

Authors:  Shoumitro Deb; Henry Kwok; Marco Bertelli; Luis Salvador-Carulla; Elspeth Bradley; Jennifer Torr; Jarret Barnhill
Journal:  World Psychiatry       Date:  2009-10       Impact factor: 49.548

2.  Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study.

Authors:  John A Tsiouris; Soh-Yule Kim; W Ted Brown; Jill Pettinger; Ira L Cohen
Journal:  J Autism Dev Disord       Date:  2013-03

3.  [Family Burden in the Case of Intellectual Disability and a Comorbid Mental Disorder].

Authors:  Amelie Werner; Elke Voß; Hans Joachim Salize; Bernd Puschner; Maja Stiawa; Andrea Koch; Matthias Schützwohl
Journal:  Psychiatr Prax       Date:  2015-10-21

Review 4.  Assessment and treatment of challenging behaviour for individuals with intellectual disability: a research review.

Authors:  Blair P Lloyd; Craig H Kennedy
Journal:  J Appl Res Intellect Disabil       Date:  2014-01-25

5.  Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.

Authors:  Shang-Wei Hsu; Po-Huang Chiang; Yu-Chia Chang; Jin-Ding Lin; Ho-Jui Tung; Chao-Yun Chen
Journal:  Res Dev Disabil       Date:  2013-12-13

6.  Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorders among a community-based population aged between 16 and 64 years.

Authors:  S Deb; M Thomas; C Bright
Journal:  J Intellect Disabil Res       Date:  2001-12

7.  Client Socio-Demographic and Service Receipt Inventory--European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs.

Authors:  D Chisholm; M R Knapp; H C Knudsen; F Amaddeo; L Gaite; B van Wijngaarden
Journal:  Br J Psychiatry Suppl       Date:  2000

8.  Proxy and self-reported Quality of Life in adults with intellectual disabilities: Impact of psychiatric symptoms, problem behaviour, psychotropic medication and unmet needs.

Authors:  Andrea D Koch; Anke Vogel; Thomas Becker; Hans-Joachim Salize; Elke Voss; Amelie Werner; Katrin Arnold; Matthias Schützwohl
Journal:  Res Dev Disabil       Date:  2015-07-31

9.  Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.

Authors:  Børge Holden; Jens Petter Gitlesen
Journal:  Res Dev Disabil       Date:  2004 Nov-Dec

10.  Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.

Authors:  Rory Sheehan; Angela Hassiotis; Kate Walters; David Osborn; André Strydom; Laura Horsfall
Journal:  BMJ       Date:  2015-09-01
View more
  1 in total

1.  [Mental health in persons with intellectual disability].

Authors:  Matthias Schützwohl; Tanja Sappok
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.